@FiercePharma: Digesting $13B Nycomed buyout, #Takeda chief says Japanese managers aren't adept at integrating acquisitions - WSJ. Report | Follow @FiercePharma
> Switzerland's Acino has agreed to buy Cephalon's ($CEPH) business in the Middle East and Africa for €80 million, including €60 million in cash. Article
> Watson Pharmaceuticals ($WPI) has asked the FDA to approve its generic version of Noven Pharmaceuticals' ADHD treatment Daytrana. Noven responded by suing for patent infringement. Story
> New York-based drug importer Medisca pleaded guilty to a misdemeanor and admitted it had claimed its unapproved, Chinese-made human growth hormone was cleared by the FDA. Report
> Some Indian patient groups and industry leaders are questioning whether the country's Competition Commission is qualified to police foreign M&A as new proposals would require. News
> Johnson & Johnson ($JNJ) plans to release its third-quarter results Tuesday morning before the market opens. Item
> Apotex got the FDA nod for Ferriprox, its treatment for the iron-related blood disorder thalassemia. Article
> Actavis donated $2.7 million worth of medicines, including heart drugs and anti-infectives, to Libya to help alleviate local shortages. Story
Biotech News
@FierceBiotech: Twitter opinions linked to vaccine uptake. Item | Follow @FierceBiotech
@JohnCFierce: My first reaction to the Anadys deal? Looks like Roche is figuring that if it's worth anything, they got it cheap. Article | Follow @JohnCFierce
@RyanMFierce: FDA extends halt that began in August on Insmed's trial for inhaled antibiotic. $INSM stock takes hit. Story | Follow @RyanMFierce
@MaureenFierce: Tech needed to stop Twitter from becoming platform for pushers of fake, substandard drugs. Article By @Nick__Taylor. | Follow @MaureenFierce
> Working on a cure, Roche scoops up Anadys hep C drugs in $230M buyout. Article
> Sofinnova bucks a bleak trend with $440M biotech fund. Report
> Harvard project takes aim at improving drug development odds. Item
Medical Device News
> Boston Sci launches Promus Element stent system in China. Article
> Eucomed to launch conference pre-vetting system. Story
> Analyst names medtech firms ripe for M&A. Report
Biotech IT News
> Google Earth marks sources of infection. Article
> Robot scientist passes big bio test. Story
> Bayer tackles informatics challenges in cancer research. News
> Accelrys brings drug discovery projects to the cloud. Report
> Google VC unit takes lead role DNAnexus's $15M round, hosting huge DNA database. Item
And Finally... To keep counterfeit drugs from setting up a beachhead on Twitter, new filtering technologies are needed, researchers say. Report